FLT3 and acute myeloid leukemia: For instance, 2-DG, through N-linked glycosylation inhibition, is able to abrogate cell surface expression and signaling of FLT3-ITD and mutated c-kit in a panel of AML cell lines and primary blasts from patients, thus inducing cell death [57].